A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.
Primary Outcome Measures
- Biospecimen & Clinical Data Collection [10 years]
To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results
Persons 18 to 85 years of age at the date of informed consent.
If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting.
Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure.
Persons younger than 18 years of age or older than 85 years of age at the date of informed consent.
Receipt of blood products 30 days before the study blood draw.
Receipt of an investigational (unapproved) drug 30 days before the study blood draw.
A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks.
Has donated a unit of blood within the last 2 months at the date of informed consent.
Contacts and Locations
|1||Sanguine Biosciences||Waltham||Massachusetts||United States||02451|
Sponsors and Collaborators
- Sanguine Biosciences
- Principal Investigator: Houman Hemmati, MD, Sanguine Biosciences
Study Documents (Full-Text)None provided.